Related Experiment Video
Updated: Aug 8, 2026

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective
1Leiden/Amsterdam Center for Drug Research, Department of Pharmacochemistry, Vrije Universiteit, Amsterdam, The Netherlands.
Abstract:
An overview is presented on the molecular aspects of toxicity due to paracetamol (acetaminophen) and structural analogues. The emphasis is on four main topics, that is, bioactivation, detoxication, chemoprevention, and chemoprotection. In addition, some pharmacological and clinical aspects are discussed briefly. A general introduction is presented on the biokinetics, biotransformation, and structural modification of paracetamol. Phase II biotransformation in relation to marked species differences and interorgan transport of metabolites are described in detail, as are bioactivation by cytochrome P450 and peroxidases, two important phase I enzyme families. Hepatotoxicity is described in depth, as it is the most frequent clinical observation after paracetamol-intoxication. In this context, covalent protein binding and oxidative stress are two important initial (Stage I) events highlighted. In addition, the more recently reported nuclear effects are discussed as well as secondary events (Stage II) that spread over the whole liver and may be relevant targets for clinical treatment. The second most frequent clinical observation, renal toxicity, is described with respect to the involvement of prostaglandin synthase, N-deacetylase, cytochrome P450 and glutathione S-transferase. Lastly, mechanism-based developments of chemoprotective agents and progress in the development of structural analogues with an improved therapeutic index are outlined.
Insights
Paracetamol (acetaminophen) toxicity involves molecular bioactivation and detoxication pathways. Understanding these mechanisms aids in developing chemoprotective agents and safer drug analogues.
Area of Science:
- Toxicology
- Pharmacology
- Molecular Biology
Background:
- Paracetamol (acetaminophen) is a common analgesic with known toxicity.
- Its toxicity is linked to molecular mechanisms including bioactivation and detoxication.
- Understanding these pathways is crucial for drug safety and development.
Purpose of the Study:
- To provide an overview of the molecular aspects of paracetamol toxicity.
- To discuss bioactivation, detoxication, chemoprevention, and chemoprotection.
- To explore clinical and pharmacological aspects of paracetamol toxicity.
Main Methods:
- Review of molecular mechanisms of paracetamol toxicity.
- Detailed description of Phase I and Phase II biotransformation pathways.
- In-depth analysis of hepatotoxicity and renal toxicity mechanisms.
Main Results:
- Hepatotoxicity involves covalent protein binding, oxidative stress, and nuclear effects.
- Renal toxicity is associated with prostaglandin synthase, N-deacetylase, cytochrome P450, and glutathione S-transferase.
- Species differences in metabolism and interorgan transport are significant.
Conclusions:
- Molecular understanding of paracetamol toxicity informs the development of chemoprotective strategies.
- Progress is being made in designing structural analogues with improved therapeutic indices.
- Further research into nuclear effects and secondary events may reveal new therapeutic targets.
Related Concept Videos
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Drug Toxicity: Overview
Drug Toxicity: Dose-Dependent Reactions
Drug toxicity: Idiosyncratic Reactions
Drug toxicity: Drug–Drug Interaction
Pharmaceutical Poisoning: Treatment Strategies

